Ibrutinib 11014-0327-03
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- February 16, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ibrutinib | 280 mg/1 |
Selected Package
11014-0327-03Selected1 BAG in 1 DRUM (11014-0327-3) / 62500 TABLET, FILM COATED in 1 BAG